BCAX Earnings Date: Nov 9, 2026 (Estimated) — Bicara Therapeutics Inc. Common Stock
NASDAQ · Healthcare · Biotechnology
Updated
When is BCAX's next earnings date?
Bicara Therapeutics Inc. Common Stock (BCAX) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.84.
How did BCAX do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Bicara Therapeutics Inc. Common Stock posted EPS of -$0.82 versus the -$0.82 estimate, a miss of 1.2%. Revenue was $0. The stock's 1-day post-earnings move was -14.3%.
How much does BCAX stock move after earnings?
BCAX beat EPS estimates in 1 of its last 6 reported quarters. Over the last 6 reports the stock moved an average of 5.2% (up or down) in the day after earnings.
About Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transforming growth factor beta (TGF-b). Bicara Therapeutics operates as a subsidiary of Biocon Limited.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.82 | -0.82 | -1.23% | $0 | ❌ Miss | -14.32% | -10.06% | -14.75% |
| 2026-05-11 | Q1 2026 | -0.65 | -0.93 | -43.08% | $0 | ❌ Miss | +1.51% | -10.41% | -8.95% |
| 2026-03-30 | Q4 2025 | -0.68 | -0.68 | +0.00% | — | ➖ Inline | +3.65% | +13.50% | +19.32% |
| 2025-11-10 | Q3 2025 | -0.54 | -0.67 | -24.07% | $0 | ❌ Miss | -4.85% | +0.96% | +27.87% |
| 2025-08-12 | Q2 2025 | -0.54 | -0.50 | +7.41% | $0 | ✅ Beat | +4.80% | +14.81% | +19.42% |
| 2025-03-27 | Q4 2024 | -0.29 | -0.39 | -34.48% | $0 | ❌ Miss | +2.29% | +1.22% | +10.99% |
Showing last 6 quarters.